We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $116M
1-Year Est. Return 24.59%
This Fund
S&P 500
This Quarter Est. Return
-5.36%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
10 Year Est. Return
AUM
$165M
AUM Growth
Cap. Flow
+$293M
Cap. Flow %
176.95%
Top 10 Hldgs %
48.07%
Holding
59
New
59
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$121M
2
ICUI icon
ICU Medical
ICUI
+$18.3M
3
ICE icon
Intercontinental Exchange
ICE
+$9.17M
4
WWD icon
Woodward
WWD
+$8.74M
5
AVTR icon
Avantor
AVTR
+$8.51M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.42%
2 Industrials 21.2%
3 Financials 13.02%
4 Materials 5.54%
5 Utilities 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
26
Azenta
AZTA
$1.57B
$2.01M 1.21%
+40,000
New +$2.01M
HUM icon
27
Humana
HUM
$46.2B
$1.68M 1.01%
+3,443
New +$1.62M
UNH icon
28
UnitedHealth
UNH
$349B
$1.55M 0.94%
+3,080
New +$1.52M
FTV icon
29
Fortive
FTV
$17.8B
$1.48M 0.9%
+26,540
New +$1.53M
SCI icon
30
Service Corp International
SCI
$11.3B
$1.39M 0.84%
+24,392
New +$1.54M
BC icon
31
Brunswick
BC
$5.16B
$1.36M 0.82%
+17,256
New +$1.42M
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.31M 0.79%
+23,380
New +$1.32M
BKNG icon
33
Booking.com
BKNG
$159B
$1.3M 0.79%
+10,575
New +$1.28M
HOLX
34
DELISTED
Hologic
HOLX
$1.3M 0.79%
+18,775
New +$1.42M
ABBV icon
35
AbbVie
ABBV
$469B
$1.21M 0.73%
+8,149
New +$1.2M
CVSA
36
Covista Inc
CVSA
$4.51B
$1.2M 0.73%
+28,083
New +$1.19M
TMO icon
37
Thermo Fisher Scientific
TMO
$229B
$1.01M 0.61%
+1,999
New +$1.07M
BSX icon
38
Boston Scientific
BSX
$73.5B
$946K 0.57%
+17,913
New +$939K
CG icon
39
Carlyle Group
CG
$17.2B
$917K 0.55%
+30,404
New +$980K
COO icon
40
Cooper Companies
COO
$14.9B
$863K 0.52%
+10,856
New +$1M
LULU icon
41
lululemon athletica
LULU
$13B
$850K 0.51%
+2,204
New +$842K
MRK icon
42
Merck
MRK
$369B
$850K 0.51%
+8,253
New +$890K
COLM icon
43
Columbia Sportswear
COLM
$3.06B
$766K 0.46%
+10,333
New +$769K
LLY icon
44
Eli Lilly
LLY
$1.12T
$657K 0.4%
+1,224
New +$631K
CVS icon
45
CVS Health
CVS
$120B
$649K 0.39%
+9,300
New +$659K
AMP icon
46
Ameriprise Financial
AMP
$49.4B
$647K 0.39%
+1,962
New +$670K
EXAS
47
DELISTED
Exact Sciences
EXAS
$630K 0.38%
+9,237
New +$784K
AMED
48
DELISTED
Amedisys
AMED
$603K 0.36%
+6,457
New +$597K
HCA icon
49
HCA Healthcare
HCA
$88.1B
$603K 0.36%
+2,450
New +$670K
TMDX icon
50
Transmedics
TMDX
$3.22B
$597K 0.36%
+10,897
New +$784K

Similar funds

Pacific Capital Partners's Q3 2023 Portfolio in Review

Q3 2023 is the first quarter with a 13F filing on record for Pacific Capital Partners, which disclosed 59 positions worth $165M. Its ten largest holdings account for 48% of the portfolio.

Its largest position is Icon: 479,358 shares worth $3.23M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, followed by Industrials and Financials.

  • Pacific Capital Partners's largest Q3 2023 buy was Icon: 479,358 shares worth $3.23M.
  • Pacific Capital Partners's ten largest holdings make up 48% of its $165M portfolio in Q3 2023.
  • Pacific Capital Partners disclosed 59 positions in Q3 2023, its first 13F filing on record.

Based on Pacific Capital Partners's 13F filing for Q3 2023, filed 8 May 2025.